Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre- and Postoperative vs. Conventional Adjuvant Chemotherapy in Hormone Receptor-negative Breast Cancer
NCT00309569Phase 3Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Oct 1991
- Primary completion
- Sep 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 3 trial of cyclophosphamide, methotrexate, fluorouracil, epirubicin in breast cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Oct 1991; status: completed.
02
Drugs
cyclophosphamidemethotrexatefluorouracilepirubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00309569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309569.